Literature DB >> 13937706

Tetanus; the use of human hyperimmune globulin in treatment.

N S NATION, N F PIERCE, S J ADLER, R F CHINNOCK, P F WEHRLE.   

Abstract

Twenty patients with tetanus were treated with human hyperimmune globulin. The mortality rate in the series was 30 per cent. No complications due to the use of this antitoxin were observed.

Entities:  

Keywords:  GAMMA GLOBULIN; TETANUS; TETANUS ANTITOXIN

Mesh：

Substances：

Year:  1963        PMID： 13937706      PMCID： PMC1575749     

Source DB:  PubMed          Journal:  Calif Med        ISSN： 0008-1264


  8 in total

1.  Control of tetanus spasms by administration of meprobamate.

Authors:  M A PERLSTEIN
Journal:  J Am Med Assoc       Date:  1959-08-15

2.  The persistence in the human circulation of horse and human tetanus antitoxins.

Authors:  J SMOLENS; A B VOGT; M N CRAWFORD; J STOKES
Journal:  J Pediatr       Date:  1961-12       Impact factor: 4.406

3.  Rapid destruction of antitetanus serum in a patient previously sensitised to horse serum.

Authors:  M P GODFREY; V PARSONS; J R RAWSTRON
Journal:  Lancet       Date:  1960-12-03       Impact factor: 79.321

4.  The uses and results of active tetanus immunization.

Authors:  I SCHEIBEL
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

5.  Tetanus in the United States: a review of the problem.

Authors:  N W AXNICK; E R ALEXANDER
Journal:  Am J Public Health Nations Health       Date:  1957-12

6.  Absence of active immunization against infectious hepatitis; follow-up study after administration of gamma globulin.

Authors:  P F WEHRLE; W M HAMMON
Journal:  J Am Med Assoc       Date:  1958-08-23

7.  Passive immunization against tetanus with human immune globulin.

Authors:  S D RUBBO; J C SURI
Journal:  Br Med J       Date:  1962-07-14

8.  The necessity for tracheotomy in the treatment of tetanus to prevent lethal respiratory complications.

Authors:  O CREECH; J P WOODHALL; A OCHSNER
Journal:  Surgery       Date:  1950-01       Impact factor: 3.982
  8 in total
  3 in total

1.  [A HUMAN HYPERIMMUNE GAMMA GLOBULIN FOR THERAPY AND PREVENTION OF TETANUS].

Authors:  H ENGBRING; M MATTHES
Journal:  Klin Wochenschr       Date:  1965-04-15

Review 2.  Maternal and neonatal tetanus.

Authors:  C Louise Thwaites; Nicholas J Beeching; Charles R Newton
Journal:  Lancet       Date:  2014-08-19       Impact factor: 79.321

3.  The Spectrum of Clinical Characteristics and Complications of Tetanus: A Retrospective Cross-Sectional Study From a Developing Nation.

Authors:  Talal Almas; Muhammad Ali Niaz; Syed Muhammad Jawad Zaidi; Mohammad Haroon; Tarek Khedro; Reema Alsufyani; Abdulla Hussain Al-Awaid; Estelle Tran; Abdul Wali Khan; Hasan Alaeddin; Ali Rifai; Kuvira T Manamperi; Abat Khan; Abdul Haadi
Journal:  Cureus       Date:  2021-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.